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Abstract
Tachykinins are a large group of neuropeptides with both central and peripheral activity. Despite the increasing number of
studies reporting a growth supportive effect of tachykinin peptides in various in vitro stem cell systems, it remains unclear
whether these findings are applicable in vivo. To determine how neurokinin-1 receptor (NK-1R) deficient hematopoietic
stem cells would behave in a normal in vivo environment, we tested their reconstitution efficiency using competitive bone
marrow repopulation assays. We show here that bone marrow taken from NK-1R deficient mice (Tacr1
2/2) showed lineage
specific B and T cell engraftment deficits compared to wild-type competitor bone marrow cells, providing evidence for an
involvement of NK-1R signalling in adult hematopoiesis. Tachykinin knockout mice lacking the peptides SP and/or HK-1
(Tac1
2/2, Tac4
2/2 and Tac1
2/2/Tac4
2/2 mice) repopulated a lethally irradiated wild-type host with similar efficiency as
competing wild-type bone marrow. The difference between peptide and receptor deficient mice indicates a paracrine and/
or endocrine mechanism of action rather than autocrine signalling, as tachykinin peptides are supplied by the host
environment.
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Introduction
Tachykinins are a group of small neuropeptides, which share
the C-terminal motif FXGLM-NH2. In mouse, Tac1 encodes
substance P (SP) and neurokinin A (NKA) through alternative
splicing, Tac2 produces neurokinin B (NKB), and Tac4 encodes
hemokinin-1 (HK-1). Tachykinins mediate their actions through
three G-protein coupled receptors, neurokinin-1 receptor (NK-1R,
Tacr1), NK-2R (Tacr2) and NK-3R (Tacr3). While each ligand can
interact with all receptors with varying affinity, SP and HK-1 are
the preferred, endogenous ligands for NK-1R [1,2], NKA
preferentially binds to NK-2R, and NKB to NK-3R [3].
Stem cells are characterized by their ability to self-renew as well
as to generate differentiated progeny [4,5], and thus are regarded
as a promising tool for regenerative and transplantation medicine.
Embryonic stem cells are pluripotent and able to differentiate into
almost all cell types, whereas adult stem cells such as neuronal
stem cells or hematopoietic stem cells are more restricted in their
potential and are specialized to differentiate into certain cell
lineages. For example during adult hematopoiesis, hematopoietic
stem cells produce lymphoid and myeloid cells to maintain a
steady supply of immune cells.
Several studies have recently demonstrated expression and/or
growth promoting functions for neuropeptides in various in vitro
stem cell systems, including galanin [6], neuropeptide Y [7] and
substance P [8,9,10,11]. In human bone marrow, SP and NKA
have been described to exert opposing effects on hematopoiesis in
vitro via NK-1R and NK-2R [12,13]. Shahrokhi et al. showed a
significant improvement of expansion of human cord blood stem
cells when grown in the presence of SP [11]. We observed
increased cell proliferation rates of embryonic (E)14 stem cells
when grown in the presence of SP and/or HK-1 (unpublished
observation). Hong et al. reported that SP was capable of inducing
HSC to migrate to the blood and engage in tissue repair in vivo
[14]. Despite the mounting evidence for the involvement of
tachykinins in stem cell biology, limited in vivo data are available.
We wanted to expand on our recent study where we have
described the generation of the Tac4
2/2 mouse and reported a 2-
fold increase in the pro B cell population [15]. Consistent with our
in vivo data, in vitro cultures derived from Tac4
2/2 long-term
reconstituting hematopoietic stem cells contained significantly
higher absolute numbers of pro B cells compared to wild-type
cultures. Addition of HK-1 to these cultures established from long-
term reconstituting hematopoietic stem cells lead to a significant
decrease of de novo generated pro B cells, suggesting an inhibitory
role for HK-1 and its receptors in hematopoiesis [15].
In this study we sought to determine how neurokinin-1 receptor
deficient hematopoietic stem cells would behave in a normal
environment. We therefore examined whether total bone marrow
isolated from neurokinin-1 receptor deficient mice (Tacr1
2/2)
would repopulate a lethally irradiated host with similar efficiency
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e58787as wild-type bone marrow. Tachykinin knockout mice lacking the
peptides SP and/or HK-1 (Tac1
2/2, Tac4
2/2 and Tac1
2/2/
Tac4
2/2 mice) were also included in this long-term bone marrow
reconstitution study to determine whether a hematopoietic stem
cell lacking tachykinin peptides would perform differently from a
wild-type stem cell.
Materials and Methods
Animals
The following animals were used in this study: Tac4
2/2, N8,
[15]; Tac1
2/2, N10 [16] (The Jackson Laboratory, Bar Harbor,
ME, USA); Tac1
2/2/Tac4
2/2 mice, N9, [17] and Tacr1
2/2 mice,
N10 [18]. C57BL/6 breeding pairs were purchased from the
Jackson Laboratory (Bar Harbor, ME, USA), bred in-house and
used as wild-type controls. Mice were housed under specific
pathogen-free conditions at a constant temperature (22u62u)o na
12-hour light-dark cycle (light cycle: 6 am–6 pm). Food and water
were available ad libitum. Animal experiments were approved by
the University Health Network Animal Care Committee and
performed in compliance with current institutional guidelines. All
of the genetically altered mouse strains (Tac4
–/–, Tac1
–/–, Tacr1
–/–,
Tac1
–/–/Tac4
–/–) are genotyped on a regular basis including time
points before and after the experiments reported in this
manuscript. The results of one such analysis, which was done
shortly after the experiments reported here, are shown in Fig. S1.
Bone marrow transplants and competitive in vivo
repopulation assays
Bone marrow was harvested by flushing femurs and tibias with
injection media (IBSS containing 0.5% FBS and 3% kit ligand
conditioned media) [4], and the cell suspension was filtered and
counted. For the competitive in vivo repopulation, bone marrow
cells from a donor mouse (C57BL/6, Tac1
–/–, Tac4
–/–, Tac1
–/–/
Tac4
–/– or Tacr1
–/–; Ly5.2-Gpi1
b/b) were mixed 1:1 with bone
marrow cells from a wild-type mouse of the same strain as the
recipient mouse (C57BL/6, Ly5.1-Gpi1
a/a). The mixture of cells
was intravenously injected into lethally irradiated (9 Gy, Cs
137)8 –
12 week old Ly5.1-Gpi1
a/a recipient mice, with each recipient
receiving 1610
6 donor (Ly5.2-Gpi1
b/b) and 1610
6 competitor
(Ly5.1-Gpi1
a/a) bone marrow cells. The contribution of donor to
recipient blood T cells (CD3
+), B cells (B220
+), myeloid cells
(Mac1/Gr1
+) and red blood cells (Gpi1) was assessed 8, 16, 24 and
32 weeks post bone marrow transplantation by flow cytometry. To
establish the proportion of Ly5.2-Gpi1
b/b+ red blood cells,
erythrocyte Gpi1 isoforms were resolved on sepharose membranes
and quantitated as described [5]. Four independent reconstitution
experiments were performed. Up to five individual mice per strain
were injected in each experiment. Each knockout strain was
graphed versus the wild-type strain and differences were analyzed
for each time point separately using Student’s t-test (Prism Graph
Pad).
FACS analysis of bone marrow and thymus
Bone marrow was flushed with sterile PBS containing 3% fetal
calf serum (FCS). Thymus was forced through a 40 mm nylon cell
strainer (BD Biosciences, Mississauga, Canada) in sterile PBS
containing 3% FCS. Cells were centrifuged for 5 min at
1250 rpm. After red blood cell lysis, cells were resuspended in
PBS with 3% FCS. Cells were stained for 30 min at 4uC with a
combination of antibodies commonly used for analysis of immune
cells. Antibodies were directly conjugated to FITC, PE, biotin or
APC and were purchased from BD Biosciences (Mississauga,
Canada). PerCP Streptavidin (Streptavidin-Peridinin Chlorophyll-
a Protein) was used to stain cells in combination with biotinylated
primary antibodies. FACS analysis was performed on FACS
Calibur (BD Biosciences, Mississauga, Canada) and data analysis
was conducted using Cell Quest Pro. All experiments were
performed using female mice, 8–12 weeks old. Every FACS
experiment included age-matched sets of knockout and wild-type
control mice.
In vitro B cell experiments
For proliferation assays, bone marrow cells were seeded into B
cell media (Opti-MEM with 10% non-heat inactivated FCS
(Invitrogen, Carlsbad, CA, USA), 16Penicillin/Streptomycin and
5.5610
25 M 2-Mercaptoethanol) containing the appropriate
growth factors (proliferation assay bone marrow: 5610
4 cells/96
well, growth factors/stimulants: no stimulation, 1 ng/ml IL-7, IL-
3 (supernatant, 1:100). Plates were pulsed on day four with
3H-
thymidine (0.5 mCi/well), incubated at 37uC for 6 hours and
harvested onto Uni-Filter-96, GF/C plates (Perkin Elmer, Shelton,
CT, USA) using a plate harvester. The filter plates were dried,
scintillation fluid was added and plates were measured using a
Scintillation counter.
IL-7 frequency analysis was carried out by plating bone marrow
cells in 200 ml B cell media containing 1 ng/ml IL-7 in 96 well
plates (cell density: 100, 200, 400 and 800 cells/well). Wells were
scored for the frequency of IL-7 responsive cells on day seven as
previously described [19].
Hematopoietic progenitor cell isolation, OP9 co-cultures
and flow cytometry
Hematopoietic progenitor cells from LSK bone marrow cells
were sorted by flow cytometry for CD117
+ Sca1
+ Lin
2 (CD4
2
CD8
2 B220
2 CD11b
2 CD19
2) cells, using either FACS-DIVA
(BD-Biosciences) or FACS-Aria (BD-Biosciences) flow cytometers,
and sorted cells were determined .99% pure by post-sort analysis.
1610
4 hematopoietic progenitor cells were seeded onto near
confluent OP9 cells [20] in 6-well plates in co-culture with aMEM
supplemented with 15% FBS (Gibco or Hyclone) and 16Penicil-
lin/Steptomycin (Invitrogen). Cytokines, human recombinant Flt3
ligand (1 ng/ml, R&D systems) and mouse IL-7 (5 ng/ml,
Peprotech), were added to the co-cultures. Cells were harvested
on day 7 for developmental progression and cellularity analysis or
further passaged onto fresh plates of near confluent OP9 cells for
analysis on days 10, 14 and 18.
Cells were stained using combinations of directly conjugated
antibodies obtained from BD Pharmingen or eBiosciences. Flow
cytometry analysis was performed on the FACS Calibur (Becton
Dickinson Biosciences). Events were collected using CellQuest
software and data analyzed using FlowJo software (Tree Star Inc.).
Live cells were gated according to their Forward Scatter and Side
Scatter profiles and gated negatively on propidium iodide (pI)
staining. CD45 was used to gate lymphocyte populations and
exclude OP9 cells. Data are representative of 2–3 experiments.
Results and Discussion
An increasing number of in vitro studies has recently described
positive effects such as enhanced proliferation of stem cells grown
in the presence of tachykinins [8,9,10,11], suggesting a role for
tachykinins in stem cell biology. One of the goals of this study was
to test whether a role for tachykinins in stem cell biology could be
confirmed in vivo.
To examine how neurokinin-1 receptor deficient hematopoietic
stem cells would behave in a normal environment, we tested the
reconstitution efficiency of bone marrow taken from Tacr1
-/- mice
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irradiated recipient mice. Donor bone marrow cells (C57/BL/6;
Tacr1
—/—; Ly5.2-Gpi1
b/b) were mixed 1:1 with bone marrow cells
of a competing donor (C57BL/6, Ly5.1-Gpi1
a/a) and transplanted
into a lethally irradiated host (Ly5.1-Gpi1
a/a). In order to examine
long term reconstitution efficiency of the Ly5.2-Gpi1
b/b stem cell
population, blood was taken at 8, 16, 24 and 32 weeks after the
initial transplant and the ratio of Ly5.2-Gpi1
b/b to Ly5.1-Gpi1
a/a
cells was determined by flow cytometry.
Due to the short life span of blood cells, their continuous
production depends on hematopoietic stem cells, as only they are
able to sustain life-long self-renewal and differentiated progeny.
Different reconstituting cells can be distinguished from each other
based on the durability of engraftment. Whereas short term and
Figure 1. Analysis of the in vivo reconstitution efficiency of tachykinin knockout and wild-type mice. In vivo reconstitution efficiency for
(A) Tacr1
2/2 (NK-1R ko mice, n=10), (B) Tac4
2/2 (HK-1 ko mice, n=8), (C) Tac1
2/2 (SP/NKA ko mice, n=7) and (D) Tac1
2/2/Tac4
2/2 (SP/NKA/HK-1
double ko mice, n=8) versus C57BL/6 mice (n=10). Each graph shows four time points (8, 16, 24 and 32 weeks) when blood was drawn to assess the
donor/host reconstitution efficiency by flow cytometry. Four independent in vivo reconstitution experiments were performed and three to five
individual recipient mice per strain were injected in each experiment. The results of the four experiments were pooled. Knockout mouse strains
versus wild-type were analyzed at each time point separately using Student’s t-test. Time points where knockouts differ significantly from wild-type
are indicated and defined as follows: *p=0.01–0.05, **p=0.01–0.001 and ***p,0.001.
doi:10.1371/journal.pone.0058787.g001
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differentiated progeny for life, long term reconstituting cells are
characterized by their ability to permanently reconstitute the bone
marrow [4,5]. In a lethally irradiated host animal, long term
engraftment depends on long term reconstituting cells from the
donor, with all blood lineages originating from the transplanted
donor stem cell population.
Our long term engraftment results show that when bone
marrow cells taken from Tacr1
2/2 mice were tested in a
competitive setting, we detected lineage-specific engraftment
deficits in NK-1R deficient cells as they reconstituted B and T
cell populations to a significantly lower level than the competitor
(Fig. 1A). Myeloid and red blood cell repopulation efficiencies
were not altered. Since a defective hematopoietic stem cell would
affect all lineages equally, this suggests a defect or disadvantage of
NK-1R deficient B and T precursor cells. Splenic composition
(donor versus competitor) was also examined in mice reconstituted
with a mix of NK-1R
2/2 and wild-type cells, and yielded a similar
decrease in NK-1R
2/2 B and T cells versus wild-type cells (data
not shown).
In order to test whether the lack of tachykinin peptides would
lead to a similar phenotype, we included mice deficient for SP
and/or HK-1 (Tac4
2/2, Tac1
2/2 and Tac1
2/2/Tac4
2/2 mice) in
our long-term bone marrow repopulation experiments. We show
that Tac4
2/2 bone marrow and competing wild-type bone
marrow contributed equally to engraftment of mature B, T,
Table 1. Flow cytometry analysis of bone marrow and thymus of C57BL/6 and Tacr1
2/2 mice.
C57BL/6 Tacr1
2/2
Bone marrow %%
Gated on CD19
+ cells CD43
+B220
+ pro B 17.161.2 19.061.0
CD43
2B220
low pre/immature B 55.162.0 49.262.0
CD43
2B220
high mature B 23.661.6 26.762.2
IgD
2IgM
+ immature B 13.060.7 12.561.0
IgD
+IgM
+ mature B 22.661.8 25.862.0
Gated on live cells CD11b
+Gr1
+ myeloid 28.961.4 30.662.0
Gated on CD3
+cells CD4
+CD8
2 CD4
+ T 19.661.3 18.761.1
CD4
2CD8
+ CD8
+ T 31.361.9 35.261.5
Thymus
Gated on lymphocytes CD8
2CD4
2 DN 3.460.3 5.061.1
CD8
2CD4
+ CD4
+ 10.260.6 10.160.6
CD8
+CD4
2 CD8
+ 4.560.4 5.660.5
CD8
+CD4
+ DP 81.960.9 79.361.7
Gated on CD3
+ cells CD8
2CD4
2 DN 3.560.3 3.360.4
CD8
2CD4
+ CD4
+ 59.361.7 57.361.0
CD8
+CD4
2 CD8
+ 20.460.9 22.060.6
CD8
+CD4
+ DP 16.861.1 16.860.6
Gated on CD4
2CD8
2 CD25
+CD44
2 DN1 29.761.1 31.561.5
CD25
+CD44
+ DN2 8.461.1 7.760.6
CD25
2CD44
+ DN3 16.161.0 17.861.2
CD25
2CD44
2 DN4 45.861.4 42.160.7
Cells were stained with a combination of antibodies commonly used for the analysis of immune cells. Flow cytometry was performed on FACSCalibur (BD Biosciences,
Mississauga, Canada) and data analysis was conducted using Cell Quest Pro. All experiments were performed using female mice, 8–12 weeks old. Each experiment
included age-matched sets of knockout and wild-type mice. Statistical analysis was performed using Prism Graph Pad. Student’s t-tests revealed no significant
differences in total cellularity or in cell populations between C57BL/6 and Tacr1
2/2 mice. Mean cell number (610
6) for bone marrow and thymus respectively were:
C57BL/6 (n=10) 79.265.6, 168.1617.2 and Tacr1
2/2 (n=11) 90.464.3, 125.7615.1. Data are presented as mean of % gated6SE.
doi:10.1371/journal.pone.0058787.t001
Table 2. T cell development on OP9-DL1 cells.
day 7 day 10 day 14 day 18
Tacr1
2/2 CD44
+
CD25
+
48.064.3 33.0615.0 8.062.7 1.660.4
WT CD44
+ CD25
+ 51.062.7 30.0614.8 8.364.5 2.861.2
Tacr1
2/2 CD44
2
CD25
+
9.761.8 63.0614.6 87.363.0 74.0618.5
WT CD44
2 CD25
+ 12.366.7 61.069.2 84.063.9 84.066.0
Tacr1
2/2 DP 0.560.4 14.068.2
WT DP 2.461.4 26.063.5
Hematopoietic stem cells (Lin
2 CD117
+ Sca1
+) isolated from bone marrow were
co-cultured with OP9-DL1 cells and analyzed by flow cytometry. The proportion
of DN2, DN3 and DP cells gated on CD45
+ are shown on days 7, 10, 14 and 18.
Analysis for the expression of CD44 and CD25 were additionally gated on CD4
2
CD8
2 CD11b
2 CD19
2 and B220
2 cells. Data are derived from 2–3 independent
experiments. All experiments were performed using female mice, 8–12 weeks
old. Each experiment included age-matched sets of knockout and wild-type
mice. Statistical analysis was performed using Prism Graph Pad. Student’s t-tests
revealed no significant differences in cell populations between wild-type and
Tacr1
2/2 mice.
doi:10.1371/journal.pone.0058787.t002
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2/2
and Tac1
2/2/Tac4
2/2 mice contributed equally to mature B and
T cell populations, but the lack of SP seemed to have a minor and
transient effect on the engraftment of the erythromyeloid lineage
(Fig. 1C and D). Despite the recently reported bone marrow B cell
phenotype of Tac4
2/2 mice which showed increased pro B cell
numbers [15], and the reported effects of SP and NKA on bone
marrow hematopoiesis [12,13], neither Tac4
2/2, Tac1
2/2, nor
Tac1
2/2/Tac4
2/2 mice lacking SP, NKA and HK-1 exhibited B
and T cell engraftment deficits similar to Tacr1
2/2 bone marrow.
Since tachykinin peptides are secreted by both surviving host cells
and by the competitor bone marrow cells, this result is not
surprising as any defect caused by the lack of tachykinin peptides
in the donor animal may be compensated by tachykinin secreting
cells in the host. Our study therefore suggests a non-autocrine
tachykininergic signalling pathway and we conclude that tachy-
kinins released by the host cells or the competitor cells compensate
for the inability of the donor cell to produce tachykinin peptide.
However, since our results demonstrate B and T cell engraftment
deficits in Tacr1
2/2 mice, this indicates a role for tachykinins in
hematopoiesis.
To follow up on the decreased B and T cell reconstitution
efficiency of Tacr1
2/2 derived bone marrow, we performed a
thorough analysis of Tacr1
2/2 primary lymphoid organs using
flow cytometry. However, all B, T and myeloid populations were
accounted for and no major deficits could be detected, suggesting
that B, T and myeloid development is not altered in these mice
(Table 1). Furthermore, in vitro development of Tacr1
2/2 bone
marrow cells was similar to wild-type controls as their response to
IL-7, GM-CSF, IL-4, GM-CSF+IL-4 and M-CSF were compa-
rable (data not shown). In addition, analysis of IL-7 cloning
efficiency, which is used to determine the frequency of IL-7
responsive B cell precursors in bone marrow, was similar between
Tacr1
2/2 and wild-type bone marrow (data not shown). No
differences in T cell development were observed between Tacr1
2/
2 and wild-type controls when bone marrow progenitors were co-
cultured on OP9-DL1 cells at all time points analysed (Table 2).
While the lack of a phenotype in primary immune organs of
Tacr1
2/2 mice suggests that NK-1R signalling is dispensable for
hematopoietic function in vivo, the significantly decreased B and T
cell engraftment of Tacr1
2/2 versus wild-type bone marrow is
intriguing. One explanation for the lower efficiency of B/T cell
engraftment of Tacr1
2/2 hematopoietic stem cells and/or
consequently its predecessors could be a slower cell proliferation
rate in the absence of tachykinin signalling. Both wild-type host
and competing bone marrow cells express SP and HK-1, which
have been shown to positively affect cell proliferation. Therefore,
in a competitive setting, wild-type cells receiving signalling through
NK-1R may proliferate faster than NK-1R deficient cells.
However, the lack of an immunological phenotype in primary
lymphoid organs together with the fact that Tacr1
2/2 mice are
capable of repopulating B and T cells per se, suggests that NK-1R
signalling does not play a key role in hematopoiesis, but rather
plays a minor modulating role as one of many signalling pathways
supporting the proliferation of B and T cells.
Supporting Information
Figure S1 Results of genotyping of litters of mice of
various mouse strains. In order to maintain the integrity of
the C57BL/6 background across all of our strains we routinely
cross our gene deleted mice to C57BL/6 WT mice and select
knockout breeders. Fig. S1 shows such an analysis. This procedure
was carried out throughout the course of these experiments, both
before and after the reported data. PCR genotyping was carried
out using the REDExtract-N-Amp
TM Tissue polymerase chain
reaction (PCR) kit (Sigma-Aldrich Inc., St. Louis, MO, USA). This
figure shows data for three of the mouse strains reported in this
manuscript (Tac1
-/-, Tac4
-/-, and Tacr1
-/-). The analysis for the 4
th
strain, double knock out Tac1
-/-/Tac4
-/-, was undertaken at the
same time but has already been published [17]. The primers used
to genotype the four knockout strains have been previously
reported as well [17].
(TIF)
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